about
Informatics and standards for nanomedicine technologyDelivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerThe Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine InductionBioavailability enhancers of herbal origin: an overviewChallenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewalMicroneedles: A New Frontier in Nanomedicine DeliveryRecent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingRecommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging fieldDelivery of host cell-directed therapeutics for intracellular pathogen clearanceThe big picture on nanomedicine: the state of investigational and approved nanomedicine productsCan nanomedicines kill cancer stem cells?Nanomedicine approaches for corneal diseasesAtherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor TreatmentSafety of Nanoparticles in MedicineLiposomes as nanomedical devicesFunctionalized positive nanoparticles reduce mucin swelling and dispersionCell delivery of therapeutic nanoparticlesEthics in nanomedicineInteractions of nanomaterials and biological systems: Implications to personalized nanomedicineNano polymeric carrier fabrication technologies for advanced antitumor therapyNanoparticles for imaging and treating brain cancerActivation of latent HIV using drug-loaded nanoparticlesTargeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imagingIntroducing micrometer-sized artificial objects into live cells: a method for cell-giant unilamellar vesicle electrofusionPET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing MiceLaser spectrometry for multi-elemental imaging of biological tissues.In Vivo Targeting of Metabolically Labeled Cancers with Ultra-Small Silica NanoconjugatesMetallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.Clinical Translation of Nanomedicine.Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.Regulation of nanomedicines in the EU: distilling lessons from the pediatric and the advanced therapy medicinal products approaches.Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.Shedding light on nanomedicine.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Nanotechnology and dentistry.In vitro suppression of oral squamous cell carcinoma growth by ultrasound-mediated delivery of curcumin microemulsions
P2860
Q23912034-F5411FCF-0F5A-413C-A8AC-2E2693F7A156Q24614491-DC517A6D-3EED-45BD-AE4B-07D80224F122Q24625344-5E317026-D875-4AF5-B84C-A8A85A49D565Q24631494-D1F32F86-C881-4076-838D-823972281C20Q24670636-A31F36A9-0CCD-45E0-9CD9-6CD42A3484C9Q26767037-81B0048E-9AB9-4B52-8F5D-4B199A016228Q26778234-5202480C-2B97-4F44-8877-8A347108C924Q26822431-991D3DCF-1D66-4204-B995-9322A6ACEDE6Q27006858-A66D4980-A35B-4B08-A7BF-20F0FE044626Q27021817-27158E1C-176C-4AB2-87F0-EA42273301B7Q27022017-8BA6895F-2669-4CFB-9863-6D6FF611B1E6Q27022253-14DE99CF-C24B-4759-AFB4-505919E12986Q27334823-14A7B96C-96B2-4D86-A733-49657F8DDB3BQ28078448-06335633-C349-481A-B197-2E5726DFD394Q28078974-8FC059AF-F635-4363-BF25-73512F1C8BAFQ28083076-A9180FC6-A1AE-44C4-9559-38D81958BFB1Q28088315-6281523D-252C-4E22-9EC0-2AEE3594CDB8Q28384444-46049BBD-F23A-41BE-AB46-9E5B80E5A0FCQ28385606-6A347DD1-1A78-4D66-AAE7-BAE9A9EE4BF9Q28389241-85ABB8D3-6D40-4474-A641-C8B1F9785792Q28391849-E2B2FAE0-A73F-4FE2-9147-FF790BE2DBF6Q28393168-CAFBD868-F242-4742-BA31-287983922B3BQ28394053-B4A8B811-8C84-4AFC-8C99-E7F9E1EDD354Q28477657-A8365ED2-E932-465F-861F-2D8B5FE5768BQ28533782-16FEC26E-1AB2-43D4-B26D-B0FAA4245D50Q28543025-9D090D68-9E7F-41B4-BC2A-5FF4C10D7894Q28546012-CFC42812-7748-4961-9C6C-B95FAE67CD13Q28654458-CC3910AB-DF7E-4296-8619-8E847B9BD8F0Q28828629-A1D37496-A96E-40B5-88DD-8C90C0B4BD16Q30009919-6B0D1EB6-407D-4519-99E9-AF4D235BEBA0Q30355939-A032DCB1-A856-4837-96DB-62B56802E950Q30362001-B8C193A6-36B8-4307-99DE-77AD6A886C98Q30376531-11878F0D-B013-40DC-B6E3-9C2C8390B003Q30383706-79D411AB-F1FA-4D64-87F1-DD6AFD78A745Q30387307-82B2AFD5-DD69-43EB-8BCB-8DBBB2AB9319Q30414688-71C3C8D3-C5C6-4559-99A5-FC46AA5A3944Q30447871-DA4B158C-5E38-4452-A590-FB9BD1ED8FE2Q30455490-C62B3D9D-D948-401D-8590-7B2DA4FA3A0FQ30458250-256EAD7F-0FD9-4AC9-901B-19A4B13DE95DQ30469832-12C76DB3-98E4-4A6B-A363-69FA40799199
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The emerging nanomedicine landscape
@ast
The emerging nanomedicine landscape
@en
The emerging nanomedicine landscape
@nl
type
label
The emerging nanomedicine landscape
@ast
The emerging nanomedicine landscape
@en
The emerging nanomedicine landscape
@nl
prefLabel
The emerging nanomedicine landscape
@ast
The emerging nanomedicine landscape
@en
The emerging nanomedicine landscape
@nl
P2093
P3181
P356
P1433
P1476
The emerging nanomedicine landscape
@en
P2093
Anne-Katrin Bock
Anwyn Dullaart
Axel Zweck
Volker Wagner
P2888
P304
P3181
P356
10.1038/NBT1006-1211
P407
P577
2006-10-01T00:00:00Z